BWXT to supply Ac-225 generation to Fusion Pharmaceuticals
BWX Technologies subsidiary BWXT Medical has agreed to provide Fusion Pharmaceuticals with generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials.
Your most critical assets deserve more than just fences and cameras. NV5’s cutting-edge layered security solutions extend detection and response beyond traditional perimeters. From advanced geospatial analytics to integrated surveillance and access control, NV5 helps you stay ahead of threats before they breach your defenses. Learn more.
BWX Technologies subsidiary BWXT Medical has agreed to provide Fusion Pharmaceuticals with generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials.
Co-60 tariffs would undermine U.S. health care, SSWG warns
In a letter to the Office of the U.S. Trade Representative, the Source Security Working Group (SSWG) is urging the U.S. government to withhold from imposing tariffs on Canadian-orgin cobalt-60...

Clarity and Nusano agree on medical isotopes deal
Australia-based Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company, has signed a supply agreement for copper-67 with Nusano, Inc., headquartered in California. Nusano...
Experts talk on developing the isotope supply chain
The American Nuclear Society recently hosted a webinar, “Securing the Isotope Supply Chain: A Growing Global Challenge,” featuring experts from a variety of private and public institutions...

IAEA meeting focuses on nuclear science and food safety
A recent three-day meeting organized by the International Atomic Energy Agency drew representatives from 14 countries to discuss links between foodborne contaminants like mycotoxins, heavy...

Missouri gets DOE grant for radioisotopes facility
The Department of Energy’s Office of Science has committed $20 million to the University of Missouri that—with a matching $20 million from the state government—will support construction...

Orano Med expands its Texas Pb-212 R&D center
Orano Group subsidiary Orano Med, a developer of targeted alpha therapies for oncology, inaugurated the expansion of its main research and development center located in Plano, Texas. The...
Canada clears Darlington to produce Lu-177 and Y-90
The Canadian Nuclear Safety Commission has amended Ontario Power Generation’s power reactor operating license for Darlington nuclear power plant to authorize the production of the medical...

Oak Ridge’s Isotek dramatically increases world supply of Th-229
Workers with Oak Ridge Office of Environmental Management contractor Isotek have surpassed a significant milestone in the supply of medical radioisotopes, extracting more than 15 grams of rare...

ANS holds Educator Training webinar on nuclear waste
A recent American Nuclear Society webinar tackled misconceptions about nuclear waste. Christopher Perfetti, an associate professor of nuclear engineering at the University of New Mexico,...

SHINE to acquire Lantheus’s SPECT business line
SHINE Technologies, a fusion company building what is set to be the world’s largest medical isotope production facility at its Wisconsin campus, announced that it has agreed to acquire the...